drugset / Trial / NCT01398618
Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
RandomizedParallel-groupOpen-labelPrevention
Summary
Though still an endemic area, the incidence of tuberculosis (TB) in Taiwan is decreasing in recent years. Further reduction in TB incidence, or even elimination should rely on treatment for LTBI. However, which is the cost-effective screening method or what is the cost-effective regimen in Taiwan is still unclear. Therefore, the investigators designed this prospective study to follow up adult household contacts with LTBI for 2 years and compare the efficacy of 9-month isoniazid and 4-month rifampicin).
Timeline
- Start
- 2011-05
- Primary completion
- 2013-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoniazid | Small molecule | 300 mg | — |
| Subject | Rifampin | Small molecule | 600 mg | — |